ArticleBMC geriatrics2025
Application of interpretable machine learning to predict activities of daily living disability in sarcopenia: insights from the CHARLS dataset.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Machine Learning Classification of Current Functional Impairment in Older Adults with Diabetes: Evidence from CHARLS 2015.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe decline in activities of daily living (ADL) among older persons is a significant public health concern. Sarcopenia is a major risk factor for ADL disability. This study aimed to develop and validate an interpretable machine learning (IML)-based model to predict ADL disability in sarcopenia patients using the China Health and Retirement Longitudinal Study (CHARLS) dataset.
methodsParticipants diagnosed with sarcopenia between 2015 and 2018 were included and divided into training and test cohorts (8:2 ratio). Data were pre-processed using the edited nearest neighbor method (ENN). The Boruta algorithm, XGBoost model, and SHAP method were employed for feature selection, prediction, and interpretation. Model performance was assessed using AUC, accuracy, sensitivity, specificity, and F1 score.
resultsADL disability occurred in 258 (22.5%) of 1146 sarcopenia patients. Key predictors identified by SHAP analysis included depression severity, walking speed, grip strength, and age. The XGBoost model achieved an AUC of 0.803 and 0.738 in the training and test sets, respectively, with good interpretability. DISCUSSION: The model demonstrated strong predictive performance and identified critical factors influencing ADL disability, underscoring the potential of IML in geriatric risk stratification.
conclusionThe IML-based model provides a scientific basis for developing health management strategies aimed at reducing ADL disability in older adults with sarcopenia, thereby improving quality of life and easing societal and familial care burdens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.